Peer-reviewed Artikel
Viruses 2019, 11(2), 134; https://doi.org/10.3390/v11020134
Twelfth International Foamy Virus Conference—Meeting Report
Herchenröder O, Löchelt M, Buseyne F, Gessain A, Soares MA, Khan AS, Lindemann D.Cancer Lett. 2018 Nov 13. pii: S0304-3835(18)30673-6. doi: 10.1016/j.canlet.2018.11.009.
DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression.
Fürst K, Steder M, Logotheti S, Angerilli A, Spitschak A, Marquardt S, Schumacher T, Engelmann D, Herchenröder O, Rupp RAW, Pützer BM.Semin Cancer Biol. 2018 Jun 29. pii: S1044-579X(18)30018-X. doi: 10.1016/j.
Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S, Solanki M, Spitschak A, Vera J, Pützer BM.Biochim Biophys Acta. 2018; 1864(6 Pt B):2315-2328.
A web platform for the network analysis of high-throughput data in melanoma and its use to investigate mechanisms of resistance to anti-PD1 immunotherapy.
Dreyer FS, Cantone M, Eberhardt M, Jaitly T, Walter L, Wittmann J, Gupta SK, Khan FM, Wolkenhauer O, Pützer BM, Jäck HM, Heinzerling L, Vera J.Eur J Microbiol Immunol (Bp) doi.org/10.1556/1886.2018.00007
Diagnostics as Prevention — A Rapid Testing-Based Strategy of Sex Workers against Sexual HIV Exposure
Hahn A, Hinz R, Meyer T, Loderstädt U, Herchenröder O, Meyer CG, Schwarz NG, Frickmann H.Epidemiol Infect. 2018 Apr 15:1-11.
HIV prevention strategies and risk of infection: a model-based analysis.
Hahn A, Hinz R, Meyer T, Loderstädt U, Herchenröder O, Meyer CG, Schwarz NG, Frickmann H.Theranostics 2018; 8(4):1106-1120.
MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistance.
Lai X, Gupta SK, Schmitz U, Marquardt S, Knoll S, Spitschak A, Wolkenhauer O, Pützer BM, Vera J.Acta Trop. 2018; 179:25–35
Pharmaceutical interactions between antiretroviral and antimalarial drugs used in chemoprophylaxis.
Zautner AE, Herchenröder O, El Moussi A, Schwarz NG, Wiemer DF, Uwe Groß U, Frickmann H.Nature Communications 8, Article number: 198 (2017)
Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signatures.
Khan FM, Marquardt S, Gupta SK, Knoll S, Schmitz U, Spitschak A, Engelmann D, Vera J, Wolkenhauer O, Pützer BM.Adv Drug Deliv Rev. 2017 Jul 20. pii: S0169-409X(17)30120-5. doi: 10.1016/j.addr.2017.07.013.
